XML 53 R44.htm IDEA: XBRL DOCUMENT v3.23.3
Collaboration Agreement and Stock Purchase Agreement with Bristol Myers Squibb - Additional Information (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Jan. 31, 2019
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]            
Preferred stock, shares issued   0   0   0
Stock Purchase Agreement with Bristol Myers Squibb | Series A-1 Preferred Stock            
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]            
Preferred stock, shares issued 14,545,450          
Bristol Myers Squibb Collaboration Agreement and Stock Purchase Agreement | BMS            
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]            
Upfront consideration payment $ 95,000          
Option to exercise additional consideration if clinical trial not completed within research term 250          
Milestone payments eligible to receive 450,000          
Bristol Myers Squibb Collaboration Agreement and Stock Purchase Agreement | BMS | IK-175            
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]            
Amount eligible to receive in case of exercise of options 50,000          
Bristol Myers Squibb Collaboration Agreement and Stock Purchase Agreement | BMS | IK-412            
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]            
Amount eligible to receive in case of exercise of options 40,000          
Bristol Myers Squibb Collaboration Agreement            
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]            
Upfront amount allocated to equity arrangements 1,800          
Transaction price allocated to revenue arrangement 78,700          
Revenue recognized which were previously included in deferred revenue   $ 1,200 $ 6,400 $ 8,500 $ 10,200  
Deferred revenue   $ 700   $ 700    
Bristol Myers Squibb Collaboration Agreement | IK-175            
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]            
Transaction price allocated to revenue arrangement 41,200          
Bristol Myers Squibb Collaboration Agreement | IK-412            
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]            
Transaction price allocated to revenue arrangement $ 37,500